Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: EU-Poland

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: L/C

    Etodolac

    • Long experience in in-house commercial manufacturing
    • Wide regulatory documentation
    Status Commercial
    Therapeutic cat. Musculo-skeletal
    Polymorphic form Crystalline racemate, none
    CAS No. 41340-25-4
    EU DMF readiness Checkbox
    CEP Checkbox
    JAPANESE DMF Checkbox
    KOREAN  DMF Checkbox
    CANADIAN  DMF Checkbox
    CADIFA Checkbox
    US DMF readiness Checkbox

    Drug description

    Etodolac is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones that cause inflammation and pain in the body. Etodolac is used to treat mild to moderate pain, osteoarthritis, or rheumatoid arthritis. Etodolac may also be used for purposes not listed in this medication guide.

     

     

    Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).

Send your message to this supplier
  • From:
  • To:
    ZF Polpharma S.A.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service